UNSPSC 85641869: Removal of radioactive element from upper extremity subcutaneous tissue and fascia, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of radioactive element from upper extremity subcutaneous tissue and fascia, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JPV01Z

UNSPSC 85641869 Removal of radioactive element from upper extremity subcutaneous tissue and fascia, open approach is a Commodity code that does not align with the recent state and local procurement activity tagged to it. The source shows no solicitations for radioactive-element removal procedures or related clinical services under this code. Instead, recent opportunities posted under this code span occupational medical surveillance, independent medical evaluations for pension disability determinations, surgical procedure carve-out benefit programs for municipal employees, emergency and specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve the removal of radioactive elements from subcutaneous tissue. This mismatch between the code's nominal scope and the actual work being solicited suggests the code is either misapplied by issuing bodies or the source data contains a systematic tagging error.

The issuing bodies include a state department (Washington State Department of Transportation), a county health system (Santa Clara County Health System), county and city employee benefit programs (Collier County, Long Beach, Phoenix), a county juvenile probation department (Harris County), and municipal pension boards (Phoenix Fire and Police Pension Boards). Geographic activity spans Arizona, California, Florida, and Washington. Because the tagged opportunities do not reflect the code's stated clinical purpose, vendors should verify code alignment before pursuit and consult directly with issuing bodies on scope definition during the RFP Q&A phase.